Note: Ingredients listed on restricted chemical lists
General Information
Version
4.1
Revision date
2020-01-13
Product name
CASODEX TABLETS
Product Synonyms
Bicalutamide tablets
1.2.1 Relevant identified uses
treatment of prostate cancer
supplier name
ASTRAZENECA PTY LTD
Emergency telephone
+44 (0) 1235 239 670
Icons in SDS
Company Information
company name
ASTRAZENECA PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets.AlderleyPark@astrazeneca.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360, H410
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
GHS Classification GHS Classification Carcinogenicity Category 2 Reproductive toxicity Category 1B Long-term (chronic) aquatic Category 1 hazard
Signal word
Danger
Hazard statements
H351 Suspected of causing cancer. H360 May damage fertility or the unborn child. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
May cause anti-androgenic effects. The product may form flammable dust clouds in air, if dust from crushed tablets is allowed to accumulate.
2.1 Classification of the substance or mixture
Carcinogenicity : Category 2 Reproductive toxicity : Category 1B Long-term (chronic) aquatic : Category 1 hazard
